123 related articles for article (PubMed ID: 2579548)
1. Tetrahydrouridine, cytidine analogues, and hemoglobin F.
DeSimone J; Heller P; Molokie RE; Hall L; Zwiers D
Am J Hematol; 1985 Mar; 18(3):283-8. PubMed ID: 2579548
[TBL] [Abstract][Full Text] [Related]
2. Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.
Molokie R; Lavelle D; Gowhari M; Pacini M; Krauz L; Hassan J; Ibanez V; Ruiz MA; Ng KP; Woost P; Radivoyevitch T; Pacelli D; Fada S; Rump M; Hsieh M; Tisdale JF; Jacobberger J; Phelps M; Engel JD; Saraf S; Hsu LL; Gordeuk V; DeSimone J; Saunthararajah Y
PLoS Med; 2017 Sep; 14(9):e1002382. PubMed ID: 28880867
[TBL] [Abstract][Full Text] [Related]
3. On the mechanism of Hb F elevations in the baboon by erythropoietic stress and pharmacologic manipulation.
Lavelle D; DeSimone J; Heller P; Zwiers D; Hall L
Blood; 1986 Apr; 67(4):1083-9. PubMed ID: 2420395
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and pharmacological evaluation of fluorinated tetrahydrouridine derivatives as inhibitors of cytidine deaminase.
Ferraris D; Duvall B; Delahanty G; Mistry B; Alt J; Rojas C; Rowbottom C; Sanders K; Schuck E; Huang KC; Redkar S; Slusher BB; Tsukamoto T
J Med Chem; 2014 Mar; 57(6):2582-8. PubMed ID: 24520856
[TBL] [Abstract][Full Text] [Related]
5. Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine.
Lavelle D; Vaitkus K; Ling Y; Ruiz MA; Mahfouz R; Ng KP; Negrotto S; Smith N; Terse P; Engelke KJ; Covey J; Chan KK; Desimone J; Saunthararajah Y
Blood; 2012 Feb; 119(5):1240-7. PubMed ID: 22160381
[TBL] [Abstract][Full Text] [Related]
6. On the interaction of 3,4,5,6-tetrahydrouridine with human liver cytidine deaminase.
Wentworth DF; Wolfenden R
Biochemistry; 1975 Nov; 14(23):5099-105. PubMed ID: 53069
[TBL] [Abstract][Full Text] [Related]
7. Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2'-deoxycytidine by human cytidine deaminase.
Laliberté J; Marquez VE; Momparler RL
Cancer Chemother Pharmacol; 1992; 30(1):7-11. PubMed ID: 1375134
[TBL] [Abstract][Full Text] [Related]
8. Fetal hemoglobin production in adult baboons by 5-azacytidine or by phenylhydrazine-induced hemolysis is associated with hypomethylation of globin gene DNA.
DeSimone J; Heller P; Schimenti JC; Duncan CH
Prog Clin Biol Res; 1983; 134():489-500. PubMed ID: 6198662
[TBL] [Abstract][Full Text] [Related]
9. 5-Azacytidine and fetal hemoglobin.
Heller P; DeSimone J
Am J Hematol; 1984; 17(4):439-47. PubMed ID: 6208778
[TBL] [Abstract][Full Text] [Related]
10. On the induction of fetal hemoglobin by butyrates: in vivo and in vitro studies with sodium butyrate and comparison of combination treatments with 5-AzaC and AraC.
Constantoulakis P; Knitter G; Stamatoyannopoulos G
Blood; 1989 Nov; 74(6):1963-71. PubMed ID: 2478217
[TBL] [Abstract][Full Text] [Related]
11. Promoter sequence differences may determine maximal hemoglobin F levels in 5-azacytidine treated baboons.
Lavelle DE; DeSimone J
Prog Clin Biol Res; 1989; 316A():261-8. PubMed ID: 2480610
[No Abstract] [Full Text] [Related]
12. 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons.
DeSimone J; Heller P; Hall L; Zwiers D
Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4428-31. PubMed ID: 6181507
[TBL] [Abstract][Full Text] [Related]
13. Plasma pharmacokinetics and oral bioavailability of 3,4,5,6-tetrahydrouridine, a cytidine deaminase inhibitor, in mice.
Beumer JH; Eiseman JL; Parise RA; Florian JA; Joseph E; D'Argenio DZ; Parker RS; Kay B; Covey JM; Egorin MJ
Cancer Chemother Pharmacol; 2008 Aug; 62(3):457-64. PubMed ID: 18008070
[TBL] [Abstract][Full Text] [Related]
14. Subchronic oral toxicity study of decitabine in combination with tetrahydrouridine in CD-1 mice.
Terse P; Engelke K; Chan K; Ling Y; Sharpnack D; Saunthararajah Y; Covey JM
Int J Toxicol; 2014; 33(2):75-85. PubMed ID: 24639139
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies of the cytostatic action and metabolism of 5-azacytidine and 5,6-dihydro-5-azacytidine.
Voytek P; Beisler JA; Abbasi MM; Wolpert-DeFilippes MK
Cancer Res; 1977 Jul; 37(7 Pt 1):1956-61. PubMed ID: 67884
[TBL] [Abstract][Full Text] [Related]
16. Influence of tetrahydrouridine on the pharmacokinetics of intrathecally administered 1-beta-D-arabinofuranosylcytosine.
Riccardi R; Chabner B; Glaubiger DL; Wood J; Poplack DG
Cancer Res; 1982 May; 42(5):1736-9. PubMed ID: 6896013
[TBL] [Abstract][Full Text] [Related]
17. Combinations of tetrahydrouridine and cytosine arabinoside in mouse tumors.
Kreis W; Hession C; Soricelli A; Scully K
Cancer Treat Rep; 1977 Oct; 61(7):1355-64. PubMed ID: 589601
[TBL] [Abstract][Full Text] [Related]
18. Epimer interconversion, isomerization, and hydrolysis of tetrahydrouridine: implications for cytidine deaminase inhibition.
Xiang TX; Niemi R; Bummer P; Anderson BD
J Pharm Sci; 2003 Oct; 92(10):2027-39. PubMed ID: 14502542
[TBL] [Abstract][Full Text] [Related]
19. Induction of hemoglobin F synthesis in patients with beta thalassemia.
Ley TJ; Nienhuis AW
Annu Rev Med; 1985; 36():485-98. PubMed ID: 2581500
[TBL] [Abstract][Full Text] [Related]
20. Combined inhibition of histone deacetylase and cytidine deaminase improves epigenetic potency of decitabine in colorectal adenocarcinomas.
Tang Z; Liu L; Borlak J
Clin Epigenetics; 2023 May; 15(1):89. PubMed ID: 37208732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
